• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by Silvergate Capital Corporation

    12/1/23 4:06:22 PM ET
    $SI
    Medical/Dental Instruments
    Health Care
    Get the next $SI alert in real time by email
    S-8 POS 1 s-8pos.htm POST-EFFECTIVE AMENDMENT NO. 1

    As filed with the Securities and Exchange Commission on December 1, 2023
      
    Registration No. 333-234819
    Registration No. 333-260198

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     

    POST-EFFECTIVE AMENDMENT NO. 1 TO
    FORM S-8 REGISTRATION STATEMENT NO. 333-234819
    FORM S-8 REGISTRATION STATEMENT NO. 333-260198
    UNDER
    THE SECURITIES ACT OF 1933


     
    SILVERGATE CAPITAL CORPORATION
     (Exact name of registrant as specified in its charter)



    Maryland
    (State or other jurisdiction of incorporation
    or organization)

    4250 Executive Square, Suite 300
    La Jolla, California
     (Address of Principal Executive Offices, Including Zip Code)
     33-0227337
    (I.R.S. Employer
    Identification No.)


    92037
    (Zip Code)
     


    Silvergate Capital Corporation 2010 Equity Compensation Plan
    Silvergate Capital Corporation 2018 Equity Compensation Plan
    Silvergate Bank 401(k) Retirement Savings Plan 
    (Full title of the plan)
     
     
    Kathleen M. Fraher
    Chief Transition Officer
    Silvergate Capital Corporation
    4250 Executive Square, Suite 300
    La Jolla, CA 92037
    (Name and address of agent for service)
     
    Telephone: (858) 362-6300
    (Telephone number, including area code, of Agent for Service)
     
     
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
     
    Large accelerated filer
    ☐
     
    Accelerated filer
    ☐
    Non-accelerated filer
    ☒
     
    Smaller reporting company
    ☒
         
    Emerging Growth company
    ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  ☐



    EXPLANATORY NOTE / DEREGISTRATION OF SECURITIES

    These post-effective amendments (each, a “Post-Effective Amendment” and, collectively, the “Post-Effective Amendments”) relate to the following Registration Statements on Form S-8 (each, a “Registration Statement” and, collectively, the “Registration Statements”) filed by Silvergate Capital Corporation, a Maryland corporation (the “Registrant”), with the Securities and Exchange Commission (the “SEC”):


    ●
    Registration Statement on Form S-8 (333-234819), filed with the SEC on November 22, 2019, which registered (i) 632,159 shares of the Registrant’s Class A common stock, par value $0.01 per share (the “Common Stock”), issuable under the Silvergate Capital Corporation 2010 Equity Compensation Plan and (ii) 1,596,753 shares of Common Stock issuable under the Silvergate Capital Corporation 2018 Equity Compensation Plan; and


    ●
    Registration Statement on Form S-8 (333-260198), filed with the SEC on October 12, 2021, which registered 200,000 shares of Common Stock issuable in connection with the Silvergate Bank 401(k) Retirement Savings Plan.

    In light of the Registrant’s inability to file the reports required under the Securities Exchange Act of 1934, as amended, on a timely basis and the delisting of the Common Stock from the New York Stock Exchange, the Registrant has terminated any and all offerings of securities registered pursuant to the Registration Statements. Accordingly, the Registrant, by filing these Post-Effective Amendments, hereby terminates the effectiveness of the Registration Statements, and, in accordance with an undertaking made by the Registrant in Part II, Item 9 of each of the Registration Statements to remove from registration, by means of a post-effective amendment, any securities that had been registered for issuance but remain unsold at the termination of the offering, the Registrant hereby removes from registration any and all securities registered but which remain unsold under the Registration Statements as of the date hereof.



    SIGNATURES

    Pursuant to the requirements of the Securities Act of 1933 (the “Securities Act”), the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused these Post-Effective Amendments to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of La Jolla, State of California, on December 1, 2023.

     

    SILVERGATE CAPITAL CORPORATION  
           

    By:
    /s/ Kathleen M. Fraher  
        Name: 
    Kathleen M. Fraher  
        Title:   
    Chief Transition Officer  
           



    No other person is required to sign these Post-Effective Amendments in reliance upon Rule 478 under the Securities Act.


    Get the next $SI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SI

    DatePrice TargetRatingAnalyst
    8/25/2025$20.00Buy
    Goldman
    8/25/2025$23.00Buy
    BTIG Research
    8/25/2025$18.00Overweight
    Piper Sandler
    8/25/2025$19.00Buy
    Jefferies
    3/6/2023Neutral → Sell
    Compass Point
    3/6/2023$9.00 → $4.00Neutral → Underperform
    Wedbush
    3/2/2023$16.00 → $10.00Buy → Neutral
    Compass Point
    3/2/2023Neutral → Underweight
    JP Morgan
    More analyst ratings

    $SI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF FINANCIAL OFFICER Points Jeffrey S. exercised 13,264 shares at a strike of $2.48 and bought $25,072 worth of shares (1,600 units at $15.67), increasing direct ownership by 40% to 52,445 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    9/15/25 4:25:01 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    CEO & EXECUTIVE CHAIRMAN Ball Robert Joseph bought $122,755 worth of shares (8,000 units at $15.34), increasing direct ownership by 8% to 111,259 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    9/15/25 4:15:37 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Large owner Gilde Healthcare Holding B.V. converted options into 2,280,482 shares and bought $1,500,000 worth of shares (100,000 units at $15.00) (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    8/5/25 6:37:22 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF FINANCIAL OFFICER Points Jeffrey S. exercised 13,264 shares at a strike of $2.48 and bought $25,072 worth of shares (1,600 units at $15.67), increasing direct ownership by 40% to 52,445 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    9/15/25 4:25:01 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Officer Blue David Lawrence exercised 94,394 shares at a strike of $2.16, increasing direct ownership by 215% to 138,331 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    9/15/25 4:21:39 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    CEO & EXECUTIVE CHAIRMAN Ball Robert Joseph bought $122,755 worth of shares (8,000 units at $15.34), increasing direct ownership by 8% to 111,259 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    9/15/25 4:15:37 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty

    Partnership will Expand Shoulder Innovations' Disruptive Ecosystem with Advanced Enabling Technology, Complementing Surgeon and Patient Needs in the ASC Management to Participate in a Fireside Chat at the Piper Sandler 37th Annual Healthcare Conference Today at 8:30 a.m. ET GRAND RAPIDS, Mich., Dec. 3, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the Company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced a strategic partnership with Interventional Systems (INS), a developer of robotic solutions for minimally invasive surgery, to introduce a transformative shoulder-s

    12/3/25 7:00:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations to Participate in the Piper Sandler 37th Annual Healthcare Conference

    GRAND RAPIDS, Mich., Nov. 19, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference. The fireside chat will take place at 8:30 a.m. ET / 5:30 a.m. PT on Wednesday, December 3, 2025. A live and archived version of the fireside chat will be available on the "InvestorRelations" section of the Shoulder In

    11/19/25 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance

    GRAND RAPIDS, Mich., Nov. 11, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the third quarter ended September 30, 2025. Third Quarter & Recent Business Highlights Generated revenue of $11.8 million in the third quarter, a 58% increase over the same quarter last yearSold 1,584 total implant systems, a 53% increase over the prior year quarterAchieved gross margin of 76.2% for

    11/11/25 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Shoulder Innovations with a new price target

    Goldman initiated coverage of Shoulder Innovations with a rating of Buy and set a new price target of $20.00

    8/25/25 8:23:10 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Piper Sandler initiated coverage on Shoulder Innovations with a new price target

    Piper Sandler initiated coverage of Shoulder Innovations with a rating of Overweight and set a new price target of $18.00

    8/25/25 8:22:49 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    BTIG Research initiated coverage on Shoulder Innovations with a new price target

    BTIG Research initiated coverage of Shoulder Innovations with a rating of Buy and set a new price target of $23.00

    8/25/25 8:22:49 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    SEC Filings

    View All

    Shoulder Innovations Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    12/3/25 7:10:53 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Shoulder Innovations Inc.

    10-Q - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    11/12/25 4:10:24 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    11/12/25 9:13:28 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Silvergate Capital Corporation (Amendment)

    SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)

    2/12/24 12:17:13 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Silvergate Capital Corporation (Amendment)

    SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)

    5/22/23 4:03:17 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Silvergate Capital Corporation

    SC 13G - Silvergate Capital Corp (0001312109) (Subject)

    2/14/23 4:49:34 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Leadership Updates

    Live Leadership Updates

    View All

    Silvergate announces changes to its executive team

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced the promotion of Ben Reynolds to President, and appointment of Kate Fraher as Chief Risk Officer, of both the Company and its subsidiary, Silvergate Bank. In their new roles, Ben and Kate will continue reporting to Alan Lane, CEO of Silvergate and the bank. "We are excited about these new roles, which will benefit Silvergate as we continue to grow and mature as an organization," said Alan Lane, CEO of Silvergate. "Serving the digital asset industry requires that we continue to innovate and deliver prod

    11/7/22 4:30:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Announces Appointment of Mary-Margaret Henke to Board of Directors

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital currency industry, today announced the appointment of Mary-Margaret Henke to the board of directors of both the Company and its subsidiary bank, Silvergate Bank. "I am fortunate to be joining Silvergate's board during this period of continued evolution for both the bank and the digital assets industry," said Mary-Margaret Henke. "I look forward to working in tandem with my fellow Board members and management to ensure the Company remains a leader in innovative banking solutions." "Mary-Margaret's extensive knowledge of the financial

    9/19/22 4:15:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Announces Appointment of Rebecca Rettig to Board of Directors

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital currency industry, today announced the appointment of Rebecca Rettig to the board of directors for both the Company and its subsidiary bank, Silvergate Bank. "I am honored to join Silvergate's board at this moment of evolution in the bank's history and the digital asset ecosystem," said Rebecca Rettig. "I look forward to working with Silvergate's leadership and my fellow board members to strengthen the Company's leadership position in this evolving and innovative industry." "Rebecca's broad wealth of knowledge in the blockchain and

    3/16/22 9:00:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Financials

    Live finance-specific insights

    View All

    Shoulder Innovations to Report Third Quarter 2025 Financial Results on November 11, 2025

    GRAND RAPIDS, Mich., Oct. 20, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the third quarter of 2025 after market close on Tuesday, November 11, 2025. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on November 11, 2025. Those interested in listening to the conference call may do so by dialing (877) 407-8216 fo

    10/20/25 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations to Report Second Quarter 2025 Financial Results on September 9, 2025

    Company to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on the Same Day GRAND RAPIDS, Mich., Aug. 28, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the second quarter of 2025 before market open on Tuesday, September 9, 2025. On the same day, members of management will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Hea

    8/28/25 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Suspends Series A Preferred Stock Dividend

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced that the Company has suspended the payment of dividends on its 5.375% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series A, in order to preserve capital. This decision reflects the Company's focus on maintaining a highly liquid balance sheet with a strong capital position as it navigates recent volatility in the digital asset industry. The Company continues to maintain a cash position in excess of its digital asset customer related deposits. The Company's Board of Directors will re-evaluate th

    1/27/23 6:55:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care